Duloxetine ameliorates valproic acid‐induced hyperactivity, anxiety‐like behavior, and social interaction deficits in zebrafish

TP Joseph, F Zhou, LY Sai, H Chen, SL Lin… - Autism …, 2022 - Wiley Online Library
Syndromic autism spectrum disorders (ASDs) are characterized by impaired social
communication and repetitive/stereotyped behaviors. Currently available therapeutic agents …
被引用次数：28 相关文章

Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish

TP Joseph, F Zhou, LY Sai, H Chen… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Syndromic autism spectrum disorders (ASDs) are characterized by impaired social
communication and repetitive/stereotyped behaviors. Currently available therapeutic agents …

Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish

TP Joseph, F Zhou, LY Sai, H Chen, SL Lin… - Autism …, 2022 - researchwithrutgers.com
Syndromic autism spectrum disorders (ASDs) are characterized by impaired social
communication and repetitive/stereotyped behaviors. Currently available therapeutic agents …
[PDF] researchgate.net

[PDF][PDF] Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish

TP Joseph, F Zhou, LY Sai, H Chen, SL Lin… - 2021 - researchgate.net
Syndromic autism spectrum disorders (ASDs) are characterized by impaired social
communication and repetitive/stereotyped behaviors. Currently available therapeutic agents …

Duloxetine ameliorates valproic acid-induced hyperactivity, anxiety-like behavior, and social interaction deficits in zebrafish.

TP Joseph, F Zhou, LY Sai, H Chen, SL Lin… - … : Official Journal of the …, 2021 - europepmc.org
Syndromic autism spectrum disorders (ASDs) are characterized by impaired social
communication and repetitive/stereotyped behaviors. Currently available therapeutic agents …